FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways
Garima Dixit(University of Iowa), Thorsten Maretzky(University of Iowa)
Cited by 20
Related Papers
iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
|Proceedings of the National Academy of Sciences|2013|165
iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
|Proceedings of the National Academy of Sciences|2015|162
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
|Nature Communications|2011|154